Havoc
Back to home
UKTNBusiness & Tech• 2 min read

Magnitude Biosciences raises £1.3m to scale drug discovery platform

Durham University spinout Magnitude Biosciences has raised £1.3m to scale its drug discovery platform and expand its work with pharmaceutical companies. The life sciences company has developed VivoScan™, a high-throughput screening platform that uses C.

Read the full story at UKTN

Havoc links to the original reporting — the full story stays with the publisher.

Was this worth reading?Sign in to vote

More in Business & Tech

The Register

How Windows turned months of inactivity into a 7-hour update hostage situation

Windows is getting more efficient. The updates, not so much

Business & TechThe Stack

Runtime: Jev is an LLM without the LL

+ Rubrik has Mythos access and you don't, Splunk hugs servers, and an agent harness for Kubernetes.

Business & TechThe Register

Agentic security is the billion-dollar challenge for some clever startup to solve

High time to stop kicking the security can down the road, investor tells The Reg

Business & Tech